Skip to content
Home/Companies/Biotech/Adicet Bio
Adicet Bio

Adicet Bio

Biotech·US·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Adicet Bio?

Adicet Bio is currently owned by Abingworth through Abingworth Bioventures VII (2018 vintage), since 2021.

Hand-verified · updated 2026-06-07

Abingworth
Investor
Abingworth
Abingworth Bioventures VII · 2018 · Life Sciences VC

Key facts

HQUS
SectorBiotech
StatusActive
Websitewww.adicetbio.com

More from Abingworth Bioventures VII

Other portfolio companies in the same fund.

Soteria Biotherapeutics
Soteria Biotherapeutics
Active
BiotechUS· 2021
Atsena Therapeutics
Atsena Therapeutics
Active
BiotechUS· 2020
Orbus Therapeutics
Orbus Therapeutics
Active
BiotechUS· 2020
Q32 Bio
Exited 2024
BiotechUS· 2020
to Homology Medicines, Inc.
Scorpion Therapeutics
Scorpion Therapeutics
Exited 2025
BiotechUS· 2020
to Eli Lilly
Spruce Biosciences
Spruce Biosciences
Exited 2020
BiotechUS· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue